Sign in

CIK 0001936258

  • Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
Open-market buys, last 90 days
$226,500
in 1 filing
Open-market sales, last 90 days
$4,661,919
in 3 filings, $4.6M under 10b5-1 plans

Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-07 Gulfo Adele M. Director Grant or award +3,400 14,260
2026-01-07 Gulfo Adele M. Director Grant or award · Option (right to buy) +15,300 15,300
2025-04-15 Gulfo Adele M. Director Grant or award +10,860 10,860
2025-04-15 Gulfo Adele M. Director Grant or award · Option (right to buy) +50,700 50,700

Page 1 of 1 · 4 trades